This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by AKSNES, L. Articles by AARSKOG, D. Search for Related Content PubMed PubMed Citation Articles by AKSNES, L. Articles by AARSKOG, D.

Plasma Concentrations of Vitamin D Metabolites in Puberty: Effect of Sexual Maturation and Implications for Growth^*

Department of Pediatrics, University of Bergen N-5016 Bergen, Norway

Address requests for reprints to: Dagfinn Aarskog, Department of Pediatrics, N-5016 Haukeland sykehus, Bergen, Norway.

To relate the vitamin D metabolism in puberty to sex, sexual maturation, and, indirectly, to growth velocity and cessation of growth, the plasma level of 25-hydroxy vitamin D, 1,25-dihydroxyvitamin D [1,25-(OH)₂D], 24,25-dihydroxyvitamin D [24,25-(OH)₂D], and 25,26-(OH)₂D were measured in 191 adolescents representing all stages of puberty. In girls, 1,25- (OH)₂D₃ increased from age 11 yr to a peak at 12 yr of age (P<0.0005) and then decreased. In boys, the increase occurred between 13–14 yr of age (P<0.005), with a subsequent decline. When the 1,25-(OH)₂D concentrations were related to the stage of puberty, the girls showed a maximal increase between stages 1 and 2 (P<0.0005), with a peak at stage 3, whereas the boys had a significant increase from stage 2 to a peak at stage 3 (P<0.01). In both sexes, there were subsequent significantly decreasing values to stage 4 through stage 5. The ratio of 24,25- (0H)2D to 25-hydroxyvitamin D varied inversely with the 1,25- (0H)2D concentration, with the lowest value at age 12 yr in both sexes, followed by a gradual increase to a plateau at age 15 yr in girls and 17 yr in boys. It appears that the hormones of the vitamin D system add another dimension to the endocrinology of growth and puberty.

^* This work was supported by the Norwegian Research Council for Science and the Humanities, the J. P. Broegelmann Foundation, and the Nordisk Insulin Foundation.

Received August 10, 1981.

This article has been cited by other articles:

				J. Maalouf, M. Nabulsi, R. Vieth, S. Kimball, R. El-Rassi, Z. Mahfoud, and G. El-Hajj Fuleihan Short- and Long-Term Safety of Weekly High-Dose Vitamin D3 Supplementation in School Children J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2693 - 2701. [Abstract] [Full Text] [PDF]

				M.S. Barnes, M.P. Bonham, P.J. Robson, J.J. Strain, A.S. Lowe-Strong, J. Eaton-Evans, F. Ginty, and J.M.W. Wallace Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers Multiple Sclerosis, June 1, 2007; 13(5): 670 - 672. [Abstract] [PDF]

				F. A. Tylavsky, K. A. Ryder, A. Lyytikainen, and S. Cheng Vitamin D, Parathyroid Hormone, and Bone Mass in Adolescents J. Nutr., November 1, 2005; 135(11): 2735S - 2738S. [Abstract] [Full Text] [PDF]

				T. Dietrich, K. J Joshipura, B. Dawson-Hughes, and H. A Bischoff-Ferrari Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population Am. J. Clinical Nutrition, July 1, 2004; 80(1): 108 - 113. [Abstract] [Full Text] [PDF]

				C. M. Weaver, M. Peacock, and C. C. Johnston Jr. Adolescent Nutrition in the Prevention of Postmenopausal Osteoporosis J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1839 - 1843. [Full Text]

				G. Saggese, S. Bertelloni, G. I. Baroncelli, G. Perri, and A. Calderazzi Mineral Metabolism and Calcitriol Therapy in Idiopathic Juvenile Osteoporosis Arch Pediatr Adolesc Med, April 1, 1991; 145(4): 457 - 462. [Abstract] [PDF]